Parthenon Therapeutics CEO exits weeks after co-founder leaves
Parthenon Therapeutics’ CEO and co-founder Laurent Audoly is no longer steering the ship of the cancer biotech, Endpoints News has learned.
Audoly’s departure comes just weeks after co-founder and chief business and operating officer Olga Granaturova left to take on the same posts at Normunity, another privately-held immunotherapy startup. CSO Tamas Oravecz also traded in his CSO hat for the same role at Simcere last August.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.